CLINICAL_TRIALS
trial_result
· 2024-04-15
Clinical Trial Update: BI 894999 First in Human Dose Finding Study in Advanced Malignancies [Phase 1]
Summary
First-in-human Phase 1 dose-finding study of BI 894999 in advanced malignancies has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Neoplasms, NUT Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2024-04-15